PURPOSE: Elevated biomarkers of inflammation and endothelial cell activation have been associated with severity of sepsis. We sought to determine the association between these baseline markers and subsequent episodes of sepsis. MATERIALS AND METHODS: We performed a nested case-control analysis using subjects from the REasons for Geographic and Racial Differences in Stroke cohort. We compared 162 sepsis cases (hospitalized for a serious infection with ≥2 systemic inflammatory response syndrome criteria) with 162 nonsepsis controls (hospitalized for a serious infection but not sepsis) matched by age, sex, and observation time epoch. Using conditional logistic regression, we evaluated the associations between sepsis and baseline levels of interleukin-6 (IL-6), tumor necrosis factor α, E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1), adjusting for smoking status, hypertension, and chronic kidney disease. RESULTS: Compared with controls, individuals with higher baseline IL-6, E-selectin, and ICAM-1 were more likely to develop sepsis (P values for trend=.02, .02, .04). Baseline tumor necrosis factor α and ICAM-1 were not associated with future sepsis (P values for trend=.29, .33). CONCLUSIONS: Individuals with higher baseline IL-6, E-selectin, and ICAM-1 were more likely to develop future sepsis episodes. These biomarkers may play a role in the early identification, mitigation, or prevention of sepsis.
PURPOSE: Elevated biomarkers of inflammation and endothelial cell activation have been associated with severity of sepsis. We sought to determine the association between these baseline markers and subsequent episodes of sepsis. MATERIALS AND METHODS: We performed a nested case-control analysis using subjects from the REasons for Geographic and Racial Differences in Stroke cohort. We compared 162 sepsis cases (hospitalized for a serious infection with ≥2 systemic inflammatory response syndrome criteria) with 162 nonsepsis controls (hospitalized for a serious infection but not sepsis) matched by age, sex, and observation time epoch. Using conditional logistic regression, we evaluated the associations between sepsis and baseline levels of interleukin-6 (IL-6), tumor necrosis factor α, E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1), adjusting for smoking status, hypertension, and chronic kidney disease. RESULTS: Compared with controls, individuals with higher baseline IL-6, E-selectin, and ICAM-1 were more likely to develop sepsis (P values for trend=.02, .02, .04). Baseline tumor necrosis factor α and ICAM-1 were not associated with future sepsis (P values for trend=.29, .33). CONCLUSIONS: Individuals with higher baseline IL-6, E-selectin, and ICAM-1 were more likely to develop future sepsis episodes. These biomarkers may play a role in the early identification, mitigation, or prevention of sepsis.
Authors: Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard Journal: Neuroepidemiology Date: 2005-06-29 Impact factor: 3.282
Authors: S J Hwang; C M Ballantyne; A R Sharrett; L C Smith; C E Davis; A M Gotto; E Boerwinkle Journal: Circulation Date: 1997-12-16 Impact factor: 29.690
Authors: Sachin Yende; Elaine I Tuomanen; Richard Wunderink; Alka Kanaya; Anne B Newman; Tamara Harris; Nathalie de Rekeneire; Stephen B Kritchevsky Journal: Am J Respir Crit Care Med Date: 2005-09-15 Impact factor: 21.405
Authors: Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay Journal: Intensive Care Med Date: 2003-03-28 Impact factor: 17.440
Authors: John A Kellum; Lan Kong; Mitchell P Fink; Lisa A Weissfeld; Donald M Yealy; Michael R Pinsky; Jonathan Fine; Alexander Krichevsky; Russell L Delude; Derek C Angus Journal: Arch Intern Med Date: 2007 Aug 13-27
Authors: Henry E Wang; John Baddley; Russell L Griffin; Suzanne Judd; George Howard; John P Donnelly; Monika M Safford Journal: Prev Med Date: 2014-04-24 Impact factor: 4.018
Authors: John P Donnelly; Sindhu Lakkur; Suzanne E Judd; Emily B Levitan; Russell Griffin; George Howard; Monika M Safford; Henry E Wang Journal: Clin Infect Dis Date: 2018-06-01 Impact factor: 9.079
Authors: Henry E Wang; John P Donnelly; Russell Griffin; Emily B Levitan; Nathan I Shapiro; George Howard; Monika M Safford Journal: Crit Care Med Date: 2016-07 Impact factor: 7.598
Authors: Junichi Ishigami; Jonathan Taliercio; Harold I Feldman; Anand Srivastava; Raymond Townsend; Debbie L Cohen; Edward Horwitz; Panduranga Rao; Jeanne Charleston; Jeffrey C Fink; Ana C Ricardo; James Sondheimer; Teresa K Chen; Myles Wolf; Tamara Isakova; Lawrence J Appel; Kunihiro Matsushita Journal: Am J Epidemiol Date: 2020-05-05 Impact factor: 4.897
Authors: Justin Xavier Moore; Tomi Akinyemiju; Alfred Bartolucci; Henry E Wang; John Waterbor; Russell Griffin Journal: Cancer Epidemiol Date: 2018-05-25 Impact factor: 2.984
Authors: Justin Xavier Moore; Tomi Akinyemiju; Alfred Bartolucci; Henry E Wang; John Waterbor; Russell Griffin Journal: J Intensive Care Med Date: 2018-06-03 Impact factor: 3.510
Authors: Mythreyi Mahalingam; Justin Xavier Moore; John P Donnelly; Monika M Safford; Henry E Wang Journal: J Intensive Care Med Date: 2017-07-05 Impact factor: 3.510
Authors: J X Moore; N A Zakai; M Mahalingam; R L Griffin; M R Irvin; M M Safford; J W Baddley; H E Wang Journal: J Thromb Haemost Date: 2016-09-23 Impact factor: 5.824